Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
(EURECA) - Leader Institution: University of Rotterdam (NL) - Duration of DN: 48 months - General information about Doctoral Networks: https://www.horizon-europe.gouv.fr/les-reseaux-de-formation-doctorale-m
-
DNA motifs and generate reproducible mutation patterns that are detectable in cancer genomes and associated with disease aggressiveness and therapy resistance. The postdoctoral fellow will work in a
-
as a targetable vulnerability in the most aggressive brain cancer, Glioblastoma. The successful candidate will work closely with 3 other PhD Research Fellow in an interdisciplinary research consortium
-
individualized need for nursing intervention. Assesses and reassesses as appropriate for risk factors including but not limited to: risks of suicide, self injurious behavior, imminent aggression, elopement and
-
. Handles emergency or crisis situations. May be exposed to clients exhibiting assaultive or aggressive behaviors. Generally pleasant working conditions in a clean, well-lighted, and quiet to moderately loud
-
participate on interdisciplinary teams with faculty in the AgriLife Research and Extension Centers (see the list at https://agriliferesearch.tamu.edu/research-centers/) and where appropriate the Texas A&M
-
carcinoma (HCC) is an aggressive liver malignancy with limited therapeutic options. Tumor progression critically depends on cytoskeletal organization and mechanotransduction, processes in which the cytolinker
-
’ philosophy to aerospace innovation. The successful candidate is expected to leverage these resources to aggressively pursue next-generation aerospace technologies that can help to transform how aviation and
-
patients in such activities as eating, dressing, grooming, social manners and care for rooms and belongings. Assist patients in controlling aggressive or destructive behavior by providing therapeutic and/or
-
aggressive form of brain cancer, characterized by diverse and dynamic cell states that drive treatment resistance and poor prognosis. In this project, funded by the Foundation Against Cancer, you will move